Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_assertion type Assertion NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_head.
- NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_assertion description "[To our knowledge, this is the first clinical evidence of efficacy for therapeutic inhibition of TRKA in a solid tumor, illuminating a genomic-driven strategy to identify CRCs reliant on this oncogene to be clinically targeted with entrectinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_provenance.
- NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_assertion evidence source_evidence_literature NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_provenance.
- NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_assertion SIO_000772 26563355 NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_provenance.
- NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_assertion wasDerivedFrom befree-2016 NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_provenance.
- NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_assertion wasGeneratedBy ECO_0000203 NP1295562.RAIBJU9RlyWxexrMd_ZGi1PJeAMg19UxcKDkRvy8RoFkU130_provenance.